UT Southwestern deploys IBM Fusion with NVIDIA AI platform for medical research

Published 04/11/2025, 14:14
© Reuters

ARMONK, N.Y. - UT Southwestern Medical Center has become the first healthcare institution to implement the NVIDIA AI Data Platform reference design using IBM Fusion, IBM (NYSE:IBM) announced Tuesday. The tech giant, currently valued at $284.84 billion, has seen its stock surge over 41% year-to-date as it continues to strengthen its position as a prominent player in the IT Services industry according to InvestingPro data.

The deployment integrates NVIDIA RTX PRO 6000 Blackwell Server Edition GPUs, NVIDIA Networking, and NVIDIA AI Enterprise software to enhance the medical center's research capabilities.

The implementation aims to support various medical research applications, including drug discovery acceleration, patient digital avatars for clinical training, and an AI assistant to improve researcher productivity.

For drug discovery, the system utilizes NVIDIA's BioNeMo open-source framework integrated with IBM Fusion to build and train deep learning models for biomolecular discovery. The technology also powers AI-driven patient avatars that simulate clinical scenarios for training purposes.

IBM Fusion's content-aware data services automatically prepare the medical center's data for AI applications, enabling researchers to process complex datasets and obtain faster responses to semantic queries.

"IBM Fusion is engineered to help organizations conduct deep research by unifying applications and access to data across hybrid clouds to help simplify discovery and data activation that is AI-ready," said Sam Werner, GM of IBM Storage.

The system integrates with NVIDIA NeMo Retriever Microservices to deliver AI agents that utilize data indexing capabilities, providing what IBM describes as a "full stack experience" for users.

According to the company's statement, the technology is designed to support large-scale training and inferencing, potentially benefiting drug research, clinical training, and researcher productivity at the medical center.

This announcement represents one of the industry's first implementations of the NVIDIA AI Data Platform reference design for healthcare applications, based on the press release statement.

In other recent news, International Business Machines (IBM) reported its third-quarter earnings for 2025, surpassing Wall Street expectations. The company achieved an earnings per share (EPS) of $2.65, outperforming the forecasted $2.44. Additionally, IBM's revenue reached $16.33 billion, exceeding the anticipated $16.09 billion. In a separate development, IBM's Apptio launched new financial operations solutions to address rising cloud costs in AI-driven environments. The new platforms, Cloudability Governance and Kubecost 3.0, are designed to enhance visibility and control over cloud spending as AI adoption grows. These recent developments reflect IBM's strategic focus on financial performance and technological innovation.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.